a series of actions taken by the FDA since 2016 that relaxed the rules surrounding the drug and made it easier to access.
"For the sake of protecting the unborn, but also for the health and safety of women, I'm looking forward to this litigation continuing and holding the manufacturers of mifepristone accountable," Pence said. The dispute over the abortion pill's availability is the most significant to land before the Supreme Court since itlast June. Since then, more than a dozen states have imposed near-total bans or more stringent limits on abortions. In 15 states, restrictions are in place that make it harder for patients to obtain medication abortions, including by requiring the drugs to be provided by a physician, according to the Guttmacher Institute, a pro-abortion rights research organization.